The federal Project Grant award of $2,264,623 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to Vanderbilt University Medical Center (VUMC) on May 1, 2025. The grant supports advanced biomedical research focused on investigating toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The research aims to transform healthcare for military service members and the broader public through innovative and impactful...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...
The Department of the Army Medical Command awarded Vanderbilt University a $1.6 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research into Modulation of Lung and Bone Microenvironments to Treat Breast Metastases. The three-year award beginning September 15, 2022 will fund investigation into medical solutions for breast cancer that has metastasized to the lungs and bones. As part of the Military Medical Research and Development...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center a $1,500,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to promote rapid return of nerve function through the use of polyethylene glycol to repair nerves. The research will be conducted from July 1, 2021 through July 30, 2025 in Nashville, Tennessee. The Military Medical Research and Development program aims to transform military and...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,949,901.00 in funding to the Salisbury Foundation For Research And Education to conduct research on the relationship between blast exposure and cellular senescence in veterans. The award period runs from Sept. 1, 2025 to Aug. 31, 2029. The funded research aims to transform healthcare for military service members and the broader...